Chimeric Antigen Receptor (CAR) T-cell therapy harnesses the power of a patient’s own immune system to destroy cancer cells; patient comfort and safety can be enhanced with Tampa General’s use of a novel biometric device. TAMPA, Fla., March 4, 2024 /PRNewswire/ — As part of its…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.